Arachidonic Acid | Global Market Share Analysis, Trends and Competitive Strategies 2026-2031
Dublin, Aug. 17, 2026 (GLOBE NEWSWIRE) -- The "Arachidonic Acid - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.
The global arachidonic acid market was valued at USD 262.12 million in 2025 and is projected to increase from USD 272.76 million in 2026 to USD 332.92 million by 2031. The market is expected to register a compound annual growth rate of 4.06% during the 2026-2031 forecast period.
Market growth is being supported by rising demand for arachidonic acid (ARA) in infant formula, dietary supplements, pharmaceuticals, functional beverages, animal nutrition, and cosmetics. Increasing investment in microbial fermentation, plant-based production technologies, and high-purity lipid ingredients is also expanding the commercial potential of the global arachidonic acid market.
ARA-Fortified Infant Formula Drives Market Demand
Infant formula remains a major application for arachidonic acid, supported by growing emphasis on products formulated to reflect the lipid composition of human milk. Parents, healthcare professionals, and nutrition companies are increasingly prioritizing formulas containing both ARA and docosahexaenoic acid (DHA) to support infant brain development, visual function, and immune health.
Demand is particularly strong across Asia-Pacific, Latin America, and Africa, where changing breastfeeding patterns, population growth, and higher spending on premium nutrition are influencing purchasing decisions. Regulatory acceptance and scientific recommendations are encouraging infant formula manufacturers to incorporate ARA into nutritionally complete product portfolios.
Dietary Supplements and Functional Nutrition Create New Opportunities
Growing health awareness is increasing demand for dietary supplements containing functional lipids and omega fatty acids. According to a 2023 Council for Responsible Nutrition survey, 74% of adults in the United States used dietary supplements, demonstrating the scale of consumer interest in proactive health management.
ARA-based supplements are gaining visibility in sports nutrition, cognitive health, healthy aging, and immune-support formulations. Product manufacturers are introducing ARA in capsules, softgels, powders, and combination products containing DHA and other fatty acids. The expanding geriatric population and prevalence of lifestyle-related health conditions are expected to create additional opportunities for targeted nutritional products.
Alternative Omega-6 Sources and Production Costs Limit Expansion
Competition from lower-cost omega-6 fatty acids remains a significant market restraint. Linoleic acid, widely available through soybean, sunflower, and corn oils, benefits from established supply chains and scalable production. Global soybean oil use exceeded 63.87 million metric tons during 2023/24, according to the USDA Foreign Agricultural Service.
Manufacturers must also address concerns surrounding omega-6 balance, formulation requirements, and regulatory compliance. High extraction, fermentation, purification, and processing costs may restrict ARA adoption in price-sensitive mass-market applications. These factors are encouraging suppliers to improve production efficiency and develop differentiated high-purity ingredients.
Microbial Arachidonic Acid Maintains Market Leadership
Microbial sources accounted for 41.91% of arachidonic acid market revenue in 2025. Microbial fermentation, including production using Mortierella alpina, delivers consistent quality, scalable output, controlled purity, and reliable allergen management. These attributes are particularly important for infant nutrition, pharmaceutical, and cosmetic applications with stringent safety and regulatory requirements.
Plant-based ARA represents a smaller but rapidly expanding segment and is forecast to record a 5.99% CAGR through 2031. Advances involving CRISPR, algae photobioreactors, genetically modified crops, and improved extraction processes are increasing yields and commercial viability. Demand is also benefiting from vegan, clean-label, sustainability, and animal-free product trends.
Regional Arachidonic Acid Market Outlook
North America held the largest regional market share at 30.92% in 2025. Established infant formula brands, mature retail channels, and recognized regulatory pathways for ARA-rich oils support regional demand. The United States Food and Drug Administration's Generally Recognized as Safe notifications provide manufacturers with clearer commercialization routes, while Canada's openness to novel fatty acid ingredients is encouraging product innovation and competition.
Asia-Pacific is forecast to grow at a 5.59% CAGR, making it one of the most attractive arachidonic acid markets. Rising disposable income, favorable demographics, expanding aquaculture production, and demand for fortified foods are supporting growth. Regulatory updates in China are prompting reformulation activity, while India's aquaculture industry, Japan's aging population, and Australia's preference for high-purity clean-label ingredients are creating diversified demand.
Europe remains shaped by strict regulatory requirements, including limits on fat-based ARA and ongoing scientific review. Germany and France lead regional consumption of premium and organic infant formula. Retailer sustainability targets are also accelerating interest in microbial ARA as manufacturers seek lower-carbon alternatives to imported marine oils.
Market Segmentation
Competitive Landscape
The arachidonic acid market includes multinational ingredient manufacturers, biotechnology companies, pharmaceutical suppliers, and specialty chemical businesses. Companies covered in the report include Cargill, Incorporated; DSM-Firmenich AG; BASF SE; Cabio Biotech; Guangdong Runke; Merck Group; Cayman Chemical; Suntory Holdings; Qingdao Seawit Life Science; Zhejiang Weile Biotech; Hubei Fuxing Biotechnology; LGM Pharma; Avantor Sciences; Thermo Fisher Scientific; Shandong New Element Biotechnology; Hefei TNJ Chemical Industry; Xi'an Healthful Biotechnology; BIOWAY Industrial Group; and Xi'an Biof Bio-Technology.
Competitive strategies increasingly focus on fermentation capacity, ingredient purity, regulatory compliance, sustainable sourcing, and application-specific formulations. Suppliers capable of delivering consistent, traceable, and high-quality ARA are expected to benefit from expanding demand across infant nutrition, dietary supplements, pharmaceuticals, and personal care.
Key Topics Covered
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET LANDSCAPE
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising demand for ARA-fortified infant formula
4.2.2 Growing health consciousness and dietary supplement use
4.2.3 Increasing geriatric population and lifestyle-related disorders
4.2.4 Emerging aquaculture feed enrichment use-cases
4.2.5 Consumer Preference for Functional Lipids and Omega Fatty Acids
4.2.6 Growing focus on preventive healthcare and wellness products
4.3 Market Restraints
4.3.1 Competition from alternative omega-6 fatty acid sources
4.3.2 High production costs associated with arachidonic acid extraction and processing
4.3.3 Strict regulatory requirements for arachidonic acid usage in infant formula and dietary supplements
4.3.4 Price volatility of raw materials affecting production costs and market stability
4.4 Supply Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 MARKET SIZE AND GROWTH FORECASTS
5.1 By Source
5.1.1 Microbial
5.1.2 Animal-derived
5.1.3 Plant-based
5.2 By Form
5.2.1 Liquid Oil
5.2.2 Powder
5.2.3 Emulsion
5.3 By Application
5.3.1 Infant Formula
5.3.2 Dietary Supplements
5.3.3 Functional Beverages
5.3.4 Pharmaceuticals
5.3.5 Aquaculture and Animal Feed
5.3.6 Cosmetics and Personal Care
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.1.4 Rest of North America
5.4.2 South America
5.4.2.1 Brazil
5.4.2.2 Argentina
5.4.2.3 Rest of South America
5.4.3 Europe
5.4.3.1 United Kingdom
5.4.3.2 Germany
5.4.3.3 France
5.4.3.4 Italy
5.4.3.5 Russia
5.4.3.6 Rest of Europe
5.4.4 Asia-Pacific
5.4.4.1 China
5.4.4.2 India
5.4.4.3 Japan
5.4.4.4 Australia
5.4.4.5 Rest of Asia-Pacific
5.4.5 Middle East and Africa
5.4.5.1 Saudi Arabia
5.4.5.2 South Africa
5.4.5.3 Rest of Middle East and Africa
6 COMPETITIVE LANDSCAPE
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
6.4.1 Cargill, Incorporated
6.4.2 DSM-Firmenich AG
6.4.3 BASF SE
6.4.4 Cabio Biotech
6.4.5 Guangdong Runke
6.4.6 Merck Group
6.4.7 Cayman Chemical
6.4.8 Suntory Holdings
6.4.9 Qingdao Seawit Life Science
6.4.10 Zhejiang Weile Biotech
6.4.11 Hubei Fuxing Biotechnology
6.4.12 LGM Pharma
6.4.13 Avantor Sciences
6.4.14 Thermo Fisher Scientific
6.4.15 CABIO Biotech (Wuhan) Co., Ltd
6.4.16 Shandong New Element Biotechnology Co., Ltd.
6.4.17 Hefei TNJ Chemical Industry Co.,Ltd.,
6.4.18 Xi'an Healthful Biotechnology Co.,Ltd
6.4.19 BIOWAY Industrial Group LTD
6.4.20 Xi'an Biof Bio-Technology Co., Ltd.
7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK
For more information about this report visit https://www.researchandmarkets.com/r/cv87l8
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.